Adding the "medicines' back into personalized medicine to improve cancer treatment outcomes

被引：3
|
作者：
Martin, Jennifer H. [1 ,2 ]
Phillips, Elizabeth [3 ,4 ]
Thomas, David [5 ,6 ]
Somogyi, Andrew A. [7 ,8 ]
机构：
[1] Univ Newcastle, Sch Med & Publ Hlth, Callaghan, NSW 2308, Australia
[2] Univ Queensland, Diamantina Inst, Woolloongabba, Qld, Australia
[3] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA
[4] Murdoch Univ, Inst Immunol & Infect Dis, Murdoch, WA 6150, Australia
[5] St Vincents Hosp, Garvan Inst Med Res, Kinghorn Canc Ctr, Darlinghurst, NSW 2010, Australia
[6] Univ New S Wales, Fac Med, St Vincents Clin Sch, Sydney, NSW 2052, Australia
[7] Univ Adelaide, Fac Hlth Sci, Discipline Pharmacol, Adelaide, SA 5001, Australia
[8] Royal Adelaide Hosp, Dept Clin Pharmacol, Adelaide, SA 5000, Australia
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2015年 / 80卷 / 05期
关键词：
CELL LUNG-CANCER; INHIBITION; ABACAVIR; KINASE; TUMORS;
D O I：
10.1111/bcp.12690
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：929 / 931
页数：3
相关论文
共 50 条
  • [31] Design and Analysis of Cancer Clinical Trials for Personalized Medicine
    Jung, Sin-Ho
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (05):
  • [32] Circumventing Cancer Drug Resistance in the Era of Personalized Medicine
    Garraway, Levi A.
    Jaenne, Pasi A.
    CANCER DISCOVERY, 2012, 2 (03) : 214 - 226
  • [33] Cancer genomics: from discovery science to personalized medicine
    Chin, Lynda
    Andersen, Jannik N.
    Futreal, P. Andrew
    NATURE MEDICINE, 2011, 17 (03) : 297 - 303
  • [34] Integrative network modeling approaches to personalized cancer medicine
    Kidd, Brian A.
    Readhead, Ben P.
    Eden, Caroline
    Parekh, Samir
    Dudley, Joel T.
    PERSONALIZED MEDICINE, 2015, 12 (03) : 245 - 257
  • [35] Engineering neoantigen vaccines to improve cancer personalized immunotherapy
    Liu, Zaoqu
    Lv, Jinxiang
    Dang, Qin
    Liu, Long
    Weng, Siyuan
    Wang, Libo
    Zhou, Zhaokai
    Kong, Ying
    Li, Huanyun
    Han, Yilin
    Han, Xinwei
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2022, 18 (15): : 5607 - 5623
  • [36] Towards customized cancer vaccines: a promising filed in personalized cancer medicine
    Xu, Xiaoling
    Zhou, Zichao
    Li, Hui
    Fan, Yun
    EXPERT REVIEW OF VACCINES, 2021, 20 (05) : 545 - 557
  • [37] KRAS and colorectal cancer: an important step to the personalized medicine
    Lamoril, J.
    Ameziane, N.
    Deybach, J. -C.
    Bouizegarene, P.
    Bogard, M.
    IMMUNO-ANALYSE & BIOLOGIE SPECIALISEE, 2009, 24 (04): : 196 - 209
  • [38] Lung Cancer Organoids: The Rough Path to Personalized Medicine
    Rossi, Rachele
    De Angelis, Maria Laura
    Xhelili, Eljona
    Sette, Giovanni
    Eramo, Adriana
    De Maria, Ruggero
    Cesta Incani, Ursula
    Francescangeli, Federica
    Zeuner, Ann
    CANCERS, 2022, 14 (15)
  • [39] Genetic determinants of anticancer drug activity: towards a global approach to personalized cancer medicine
    Picker, Alexander
    Jackson, David B.
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2011, 11 (06) : 567 - 577
  • [40] PARP inhibitors as precision medicine for cancer treatment
    Du, Yi
    Yamaguchi, Hirohito
    Hsu, Jennifer L.
    Hung, Mien-Chie
    NATIONAL SCIENCE REVIEW, 2017, 4 (04) : 576 - 592
12345